Please find the attached Intimation for Filing of Petition under Reg. 30
Awaiting price reaction for this filing.
Cresanto Global Ltd (formerly Raymed Labs Limited) has filed a petition with the NCLT, Allahabad (Prayagraj Bench) on 28th October 2025, seeking approval to reduce its share capital under Section 66 of the Companies Act, 2013. The company has not disclosed the specific quantum or nature of the proposed capital reduction in this intimation. Section 66 filings typically involve writing off accumulated losses, cancelling unpaid share capital, or returning excess capital to shareholders. The petition awaits NCLT approval before any action takes effect.
Capital reduction through NCLT route can be positive (cleaning up balance sheet, writing off losses) or negative (returning capital, diluting book value) depending on the rationale, which is not yet disclosed. Shareholders should watch for further details on the purpose and extent of the reduction to assess its impact on share value.